Try our Advanced Search for more refined results
Dial v. Fresenius Medical Care Holdings, Inc. et al
Case Number:
1:14-cv-11101
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
- Baker McKenzie
- Conn Kavanaugh
- Dowd Bennett
- Fish & Richardson
- Hagens Berman
- Hogan Lovells
- Janet Janet
- Ketterer Browne
- Kreindler & Kreindler
- Wheeler Trigg
Companies
Sectors & Industries:
-
March 03, 2017
Fresenius Wins Bellwether Trial Over Dialysis Treatment
A federal jury in Massachusetts delivered a verdict in favor of Fresenius Medical Care Friday in a bellwether trial over its dialysis treatments, finding that the plaintiff hadn't proved her late husband died as a result of the clinic's care.
-
February 27, 2017
Fresenius Dialysis Drug Didn't Kill Patient, Jury Told
A man whose next of kin are suing Fresenius Medical Care didn't actually die from taking the company's dialysis drugs, but instead a heart attack that followed years of stunningly high blood pressure and other medical problems killed him, an expert for the company testified Monday.
-
February 21, 2017
Chemical Overload Killed Fresenius Patient, Jury Told
A North Carolina man died from an excess of chemical ingredients in the Fresenius drug NaturaLyte, an expert witness testified Tuesday in a bellwether trial over the medication.
-
February 10, 2017
Fresenius Doctor Grilled Over Label On Dialysis Drug
An attorney for a diabetes patient's next of kin who blame Fresenius Medical Care for his 2012 death questioned the man's doctor Friday about the label of dialysis drug NaturaLyte, suggesting that the company mislabeled it, didn't give the doctor enough training on how to use it and didn't warn anyone about possible deadly confusion.
-
February 08, 2017
Fresenius Drug Killed Dialysis Patient, Jury Told
Fresenius Medical Care failed to train doctors or warn the public about the risks of its dialysis drug Naturalyte, leading to the death of a North Carolina diabetic, his relatives told a Massachusetts federal jury Wednesday in opening statements at the first bellwether trial for litigants who declined to take part in a $250 million case settlement.